Antares Pharma, Inc. (ATRS)

Revenue

$41.56M

Quarterly · Period ending: · USD

ATRS logo

ATRS Revenue

Latest reported$41.56M
ATRS Quarterly Revenue ($400.00K → $41.56M)
High-resolution chart · PNG

ATRS revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Revenue — Quarterly (USD)
Period endingRevenue (USD)
41,557,000
48,730,000
48,191,000
44,978,000
42,083,000
44,133,000
40,003,000
32,384,000
33,079,000
37,839,000
34,306,000
28,433,000
23,286,000
18,821,000
17,868,000
14,162,000
12,703,000
14,038,985
15,052,397
13,416,159
12,007,459
14,196,121
13,478,763
12,228,390
12,318,772
11,803,920
11,085,752
14,420,391
8,348,037
8,402,104
6,570,581
6,326,785
5,202,195
4,744,910
5,507,824
5,837,544
4,528,222
5,501,177
5,685,917
4,523,942
6,864,542
5,427,035
3,919,037
3,542,873
3,569,547
3,281,565
3,122,060
3,050,987
3,364,086
2,581,643
2,041,172
1,661,844
2,026,403
1,767,636
1,388,582
1,390,115
1,114,378
1,976,309
1,230,674
1,806,275
2,843,738
2,016,020
756,624
859,095
636,660
733,958
443,978
492,425
554,385
715,580
613,175
691,380
725,821
928,457
1,039,959
908,302
910,126
965,316
1,232,861
1,128,613
668,971
1,208,445
596,757
1,106,153
587,169
287,440
454,900
766,854
484,047
781,862
500,000
600,000
1,600,000
350,868
700,000
800,000
900,000
1,217,023
600,000
900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.